Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging
Viruses · 2024
DOI: 10.3390/v16040537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Hiroshi Ueki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Mice, Inbred C57BL, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sumitomo Foundation, GSK Japan Research Grant, Astellas Foundation for Research on Metabolic Disorders.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often causes severe viral pneumonia. Although many studies using mouse models have examined the pathogenicity of SARS-CoV-2, COVID-19 pathogenesis remains poorly understood. In vivo imaging analysis using two-photon excitation microscopy (TPEM) is useful for elucidating the pathology of COVID-19, providing pathological insights that are not available from conventional histological analysis. However, there is no reporter SARS-CoV-2 that demonstrates pathogenicity in C57BL/6 mice and emits sufficient light intensity for two-photon in vivo imaging. Here, we generated a mouse-adapted strain of SARS-CoV-2 (named MASCV2-p25) and demonstrated its efficient replication in the lungs of C57BL/6 mice, causing fatal pneumonia. Histopathologic analysis revealed the severe inflammation and infiltration of immune cells in the lungs of MASCV2-p25-infected C57BL/6 mice, not unlike that observed in COVID-19 patients with severe pneumonia. Subsequently, we generated a mouse-adapted reporter SARS-CoV-2 (named MASCV-Venus-p9) by inserting the fluorescent protein-encoding gene Venus into MASCV2-p25 and sequential lung-to-lung passages in C57BL/6 mice. C57BL/6 mice infected with MASCV2-Venus-p9 exhibited severe pneumonia. In addition, the TPEM of the lungs of the infected C57BL/6J mice showed that the infected cells emitted sufficient levels of fluorescence for easy observation. These findings suggest that MASCV2-Venus-p9 will be useful for two-photon in vivo imaging studies of the pathogenesis of severe COVID-19 pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
- Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan.
- Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
- Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
ORCID-Profile: Hiroshi Ueki, Shun Iida, Seiya Yamayoshi, Tadaki Suzuki
Förderung
- Sumitomo Foundation
- GSK Japan Research Grant
- Astellas Foundation for Research on Metabolic Disorders
- Naito Foundation
- Ichiro Kanehara Foundation
- Uehara Memorial Foundation
- Okinaka Memorial Institute for Medical Research
- Japanese Respiratory Foundation
Zitieren
APA
Ueki, H., Kiso, M., Furusawa, Y., Iida, S., Yamayoshi, S., Nakajima, N., Imai, M., Suzuki, T., & Kawaoka, Y. (2024). Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging. Viruses. https://doi.org/10.3390/v16040537
Vancouver
Ueki H, Kiso M, Furusawa Y, Iida S, Yamayoshi S, Nakajima N, et al. Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging. Viruses. 2024. doi:10.3390/v16040537
BibTeX
@article{Ueki2024,
author = {Ueki, Hiroshi and Kiso, Maki and Furusawa, Yuri and Iida, Shun and Yamayoshi, Seiya and Nakajima, Noriko and Imai, Masaki and Suzuki, Tadaki and Kawaoka, Yoshihiro},
title = {Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16040537}
}
EUVIMED